-+ 0.00%
-+ 0.00%
-+ 0.00%

*Kyntra Bio Has Cash, Cash Equivalents, Investments, and Accounts Receivable of $109.4 M, Providing Cash Runway Into 2028

Dow Jones·03/16/2026 20:03:00

Please log in to view news